Chapter References

1. Update: Blood lead levels—United States, 1991-1994. MMWR 46:141, 1997.

2. Lanphear BP, Roghmann KJ: Pathways of lead exposure in urban children. Environ Res 74:67, 1997.

3. Pirkle JL, Brody DJ, Gunter EW, et al: The decline of blood lead levels in the United States: The National Health and Nutrition Examination Surveys. JAMA 272:284, 1994.

4. Tong S, Baghurst P, McMichael A, et al: Lifetime exposure to environmental lead and children's intelligence at 11-13 years: The Port Pirie cohort study. Br Med J 312:1569, 1996.

5. Finkelstein Y, Markowitz ME, Rosen JF: Low-level lead-induced neurotoxicity in children: An update on central nervous system effects. Brain Res Brain Res Rev 27:168, 1998.

6. Loghman-Adham M: Aminoaciduria and glycosuria following severe childhood lead poisoning. Pediatr Nephrol 12:218, 1998.

7. al Khayat A, Menon NS, Alidina MR: Acute lead encephalopathy in early infancy: Clinical presentation and outcome. Ann Trop Paediatr 17:39, 1997.

8. Centers for Disease Control and Prevention: Screening Young Children for Lead Poisoning: Guidance for State and Local Public Health Officials. Atlanta: CDC, 1997.

9. McElvaine MD, Orbach HG, Binder S, et al: Evaluation of the erythrocyte protoporphyrin test as a screen for elevated blood lead levels. J Pediatr 119:548, 1991.

10. Besunder JB, Super DM, Anderson RL: Comparison of dimercaptosuccinic acid and calcium disodium ethylene diaminetetraacetic acid versus demercaptopropanol and ethylene diaminetetraacetic acid in children with lead poisoning. J Pediatr 130:966, 1997.

11. Graziano JH, Lolacono NJ, Moulton T: Controlled study of meso-2, 3-dimercaptosuccinic acid for the management of childhood lead intoxication. J Pediatr 120:133, 1992.

12. Lifshitz M, Hashkanazi R, Phillip M: The effect of 2,3-dimercaptosuccinic acid in the treatment of lead poisoning in adults. Ann Med 29:83, 1997.

13. McKinney JD: Metabolism and disposition of inorganic arsenic in laboratory animals and humans. Environ Geochem Health 14:43, 1992.

14. Leibl B, Muckter H, Doklea E, et al: Reversal of oxophenylarsine-induced inhibition of glucose uptake in MDCK cells. Fund Appl Toxicol 27:1, 1995.

15. Beckman KJ, Bauman JL, Pimental PA, et al: Arsenic-induced torsades de pointes. Crit Care Med 19:290, 1991.

16. Park MJ, Currier M: Arsenic exposures in Mississippi: A review of cases. South Med J 84:461, 1991.

17. Hilfer RJ, Mandel A: Acute arsenic intoxication diagnosed by roentgenograms. N Engl J Med 266:663, 1962.

18. Ford M: Arsenic, in LR Goldfrank, NE Flomenbaum, NA Lewin, et al (eds): Goldfrank's Toxicologic Emergencies, 6th ed. Stamford, CT: Appleton & Lange, 1998, pp 1261-1273.

19. Muckter H, Liebl B, Reichl FX, et al: Are we ready to replace dimercaprol (BAL) as an arsenic antidote? Hum Exp Toxicol 16:460, 1997.

20. Kreppel H, Reichl FX, Forth W, Fichtl B: Lack of effectiveness of D-penicillamine in experimental arsenic poisoning. Vet Hum Toxicol 31:1, 1989.

21. Mathieu D, Mathieu-Nolf M, Germain-Alonso M, et al: Massive arsenic poisoning: Effect of hemodialysis and dimercaprol on arsenic kinetics. Intensive Care Med 18:47, 1992.

22. Nierenberg DW, Nordgren RE, Chang MB, et al: Delayed cerebellar disease and death after accidental exposure to dimethylmercury. N Engl J Med 338:1672, 1998.

23. Dell-Omo M, Muzi G, Bernard A, et al: Long-term pulmonary and systemic toxicity following intravenous mercury injection. Arch Toxicol 72:59, 1997.

24. Eto K: Pathology of Minamata disease. Toxicol Pathol 25:614, 1997.

25. Taueg C, Sanfilippo DJ, Rowens B, et al: Acute and chronic poisoning from residential exposures to elemental mercury—Michigan 1989-1990. J Toxicol Clin Toxicol 30:63, 1992.

26. Lim HE, Shim JJ, Lee SY, et al: Mercury inhalation poisoning and acute lung injury. Korean J Intern Med 13:127, 1998.

27. Korogi Y, Takahashi M, Okajima T, Eto K: MR findings of Minamata disease: Organic mercury poisoning. J Magn Reson Imaging 8:308, 1998.

28. Yoshida M, Satoh H, Igarashi M, et al: Acute mercury poisoning by intentional ingestion of mercuric chloride. Tohoku J Exp Med 182:347, 1997.

29. Roels HA, Boeckx M, Ceulemans E, et al: Urinary excretion of mercury after occupational exposure to mercury vapour and influence of the chelating agent meso-2,3-dimercaptosuccinic acid (DMSA). Br J Ind Med 48:247, 1991.

Peripheral Neuropathy Natural Treatment Options

Peripheral Neuropathy Natural Treatment Options

This guide will help millions of people understand this condition so that they can take control of their lives and make informed decisions. The ebook covers information on a vast number of different types of neuropathy. In addition, it will be a useful resource for their families, caregivers, and health care providers.

Get My Free Ebook


Post a comment